Skip to main content
Top
Published in: Immunologic Research 1-3/2009

01-07-2009

Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease

Authors: C. Schuetz, M. Hoenig, S. Gatz, F. Speth, U. Benninghoff, A. Schulz, K. M. Debatin, W. Friedrich

Published in: Immunologic Research | Issue 1-3/2009

Login to get access

Abstract

We report on 12 patients with chronic granulomatous disease transplanted with hematopoietic stem cells from matched unrelated (n = 9) or matched sibling donors (n = 3). The most common infectious complication was pulmonary aspergillosis, which nine patients had previously developed. Only 5 of 12 individuals had normal lung function prior to transplantation. At a mean follow-up of 53 months 9 of the 12 patients are alive including 7 of 9 following matched unrelated donor (MUD) transplantation. One patient died from ARDS, another from systemic BK virus infection, the third from complications of chronic graft-versus-host disease. Seven of nine surviving patients have normal lung function now. HSCT from a MUD is an option worth considering when no matched family donor is available. Restricted lung function prior to HSCT does not appear to be a limiting factor for such treatment.
Literature
1.
2.
go back to reference Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine. 2000;79:155–69.PubMedCrossRef Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine. 2000;79:155–69.PubMedCrossRef
3.
go back to reference Seger RA, Gungor T, Belohradsky BH, Blanche S, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985–2000. Blood. 2002;100:4344–50.PubMedCrossRef Seger RA, Gungor T, Belohradsky BH, Blanche S, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985–2000. Blood. 2002;100:4344–50.PubMedCrossRef
4.
go back to reference Kotzerke J, Bunjes D, Scheinberg DA. Radioimmunoconjugates in acute leukemia treatment: the future is radiant. Bone Marrow Transplant. 2005;36:1021–6.PubMedCrossRef Kotzerke J, Bunjes D, Scheinberg DA. Radioimmunoconjugates in acute leukemia treatment: the future is radiant. Bone Marrow Transplant. 2005;36:1021–6.PubMedCrossRef
5.
go back to reference Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989;114:555–60.PubMedCrossRef Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989;114:555–60.PubMedCrossRef
6.
go back to reference Hasui M. Chronic granulomatous disease in Japan: incidence and natural history. The Study Group of Phagocyte Disorders of Japan. Pediatr Int. 1999;41:589–93.PubMedCrossRef Hasui M. Chronic granulomatous disease in Japan: incidence and natural history. The Study Group of Phagocyte Disorders of Japan. Pediatr Int. 1999;41:589–93.PubMedCrossRef
7.
go back to reference The Westminster Hospitals Bone-Marrow Transplant Team. Bone-marrow transplant from an unrelated donor for chronic granulomatous disease. Lancet. 1977;1:210–3. The Westminster Hospitals Bone-Marrow Transplant Team. Bone-marrow transplant from an unrelated donor for chronic granulomatous disease. Lancet. 1977;1:210–3.
8.
go back to reference Hobbs JR, Monteil M, McCluskey DR, Jorges E, el Tumi M. CGD 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor. Eur J Pediatr. 1992;151:806–10.PubMedCrossRef Hobbs JR, Monteil M, McCluskey DR, Jorges E, el Tumi M. CGD 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor. Eur J Pediatr. 1992;151:806–10.PubMedCrossRef
9.
go back to reference Porta F, Mazzolari E, Verzeri U, et al. MUD transplant in an infant affected by chronic granulomatous disease. Bone Marrow Transplant. 2000;25:S190. Porta F, Mazzolari E, Verzeri U, et al. MUD transplant in an infant affected by chronic granulomatous disease. Bone Marrow Transplant. 2000;25:S190.
10.
go back to reference Watanabe C, Yajima S, Taguchi T, Toya K, Fujii Y, Hongo T, et al. Successful unrelated bone marrow transplantation for a patient with CGD and associated resistant pneumonitis and Aspergillus osteomyelitis. Bone Marrow Transplant. 2001;28:83–7.PubMedCrossRef Watanabe C, Yajima S, Taguchi T, Toya K, Fujii Y, Hongo T, et al. Successful unrelated bone marrow transplantation for a patient with CGD and associated resistant pneumonitis and Aspergillus osteomyelitis. Bone Marrow Transplant. 2001;28:83–7.PubMedCrossRef
11.
go back to reference Gungor T, Halter J, Klink A, Junge S, Stumpe KDM, Seger R, et al. Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation. 2005;79:1596–606.PubMedCrossRef Gungor T, Halter J, Klink A, Junge S, Stumpe KDM, Seger R, et al. Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation. 2005;79:1596–606.PubMedCrossRef
12.
go back to reference Schuetz C, Hoenig M, Schulz A, Lee-Kirsch MA, Roesler J, Friedrich W, et al. Successful unrelated bone marrow transplantation in a child with chronic granulomatous disease complicated by pulmonary and cerebral granuloma formation. Eur J Pediatr. 2007;166:785–8.PubMedCrossRef Schuetz C, Hoenig M, Schulz A, Lee-Kirsch MA, Roesler J, Friedrich W, et al. Successful unrelated bone marrow transplantation in a child with chronic granulomatous disease complicated by pulmonary and cerebral granuloma formation. Eur J Pediatr. 2007;166:785–8.PubMedCrossRef
13.
go back to reference Suzuki N, Hatakeyama N, Yamamoto M, Mizue N, Kuroiwa Y, Yoda M, et al. Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation. Int J Hematol. 2007;85:70–2.PubMedCrossRef Suzuki N, Hatakeyama N, Yamamoto M, Mizue N, Kuroiwa Y, Yoda M, et al. Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation. Int J Hematol. 2007;85:70–2.PubMedCrossRef
14.
go back to reference Bhattacharya A, Slatter M, Curtis A, Chapman CE, Barge D, Jackson A, et al. Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease. Bone Marrow Transplant. 2003;31:403–5.PubMedCrossRef Bhattacharya A, Slatter M, Curtis A, Chapman CE, Barge D, Jackson A, et al. Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease. Bone Marrow Transplant. 2003;31:403–5.PubMedCrossRef
Metadata
Title
Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease
Authors
C. Schuetz
M. Hoenig
S. Gatz
F. Speth
U. Benninghoff
A. Schulz
K. M. Debatin
W. Friedrich
Publication date
01-07-2009
Publisher
Humana Press Inc
Published in
Immunologic Research / Issue 1-3/2009
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-008-8068-3

Other articles of this Issue 1-3/2009

Immunologic Research 1-3/2009 Go to the issue